Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Plant Allergenic Extract [EPC]
Symphoricarpos Albus Fruit is a non-standardized plant allergenic extract used primarily for the diagnosis and treatment of IgE-mediated allergic sensitization to the common snowberry plant.
Name
Symphoricarpos Albus Fruit
Raw Name
SYMPHORICARPOS ALBUS FRUIT
Category
Non-Standardized Plant Allergenic Extract [EPC]
Drug Count
9
Variant Count
13
Last Verified
February 17, 2026
About Symphoricarpos Albus Fruit
Symphoricarpos Albus Fruit is a non-standardized plant allergenic extract used primarily for the diagnosis and treatment of IgE-mediated allergic sensitization to the common snowberry plant.
Detailed information about Symphoricarpos Albus Fruit
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Symphoricarpos Albus Fruit.
Symphoricarpos Albus Fruit, commonly known as the common snowberry, is utilized in clinical immunology as a non-standardized plant allergenic extract. It belongs to the class of drugs known as Non-Standardized Plant Allergenic Extracts [EPC]. These substances are complex biological mixtures derived from the fruit of the Symphoricarpos albus plant, a member of the Caprifoliaceae (honeysuckle) family. Unlike 'standardized' extracts, which have a potency measured in Bioequivalent Allergy Units (BAU), non-standardized extracts like Symphoricarpos Albus Fruit are typically labeled based on their weight-to-volume (w/v) ratio or Protein Nitrogen Units (PNU).
The primary clinical application of this extract is for the diagnosis and treatment of Type I hypersensitivity (allergic) reactions. These reactions are mediated by Immunoglobulin E (IgE) antibodies. Healthcare providers utilize these extracts to identify specific sensitivities in patients who exhibit symptoms such as allergic rhinitis (hay fever), conjunctivitis, or contact dermatitis upon exposure to the plant. The FDA regulates these extracts under the biological products framework, specifically 21 CFR Part 680, ensuring that the manufacturing process maintains consistent protein profiles even in the absence of a standardized potency assay.
At the molecular level, Symphoricarpos Albus Fruit extract works by presenting specific proteins (antigens) to the patient's immune system. In a diagnostic setting, such as skin prick testing, the extract is introduced into the epidermis. If the patient is sensitized, pre-existing IgE antibodies bound to the surface of mast cells will recognize the snowberry proteins. This recognition triggers the cross-linking of IgE receptors (FcεRI), leading to mast cell degranulation. This process releases inflammatory mediators such as histamine, leukotrienes, and prostaglandins, resulting in a localized 'wheal and flare' reaction (a raised bump surrounded by redness).
In a therapeutic context (immunotherapy or 'allergy shots'), the mechanism shifts toward desensitization or immune tolerance. By administering gradually increasing doses of the Symphoricarpos Albus Fruit extract, the healthcare provider induces a shift in the immune response from a Th2-dominated (allergic) profile to a Th1-dominated or T-regulatory (Treg) profile. This leads to the production of 'blocking antibodies' (IgG4), which compete with IgE for the allergen, effectively reducing the allergic cascade upon subsequent natural exposure.
Traditional pharmacokinetic studies (absorption, distribution, metabolism, and excretion) are not typically performed for allergenic extracts like Symphoricarpos Albus Fruit because they are not systemic drugs in the conventional sense. Instead, their 'pharmacokinetics' are viewed through the lens of immunological processing.
Symphoricarpos Albus Fruit extract is indicated for the following:
Symphoricarpos Albus Fruit extract is available in the following forms:
> Important: Only your healthcare provider can determine if Symphoricarpos Albus Fruit is right for your specific condition. Because of the risk of severe allergic reactions, this product must only be administered by clinicians trained in the management of anaphylaxis.
Dosage for Symphoricarpos Albus Fruit extract is highly individualized and must be determined by an allergist or immunologist based on the patient's sensitivity levels. There is no standard 'one-size-fits-all' dose.
Symphoricarpos Albus Fruit extract may be used in children, but extreme caution is required. Dosing is generally based on the same principles as adult dosing—starting with very low concentrations and escalating based on local and systemic tolerance. Children under the age of 5 may be at higher risk for systemic reactions and may have difficulty communicating early symptoms of anaphylaxis. Pediatric use must be supervised by a specialist.
No specific dosage adjustments are required for patients with renal impairment, as the extract is not cleared through the kidneys in a manner that affects its immunological activity.
No dosage adjustments are necessary for patients with hepatic impairment.
Elderly patients may have a reduced skin response to testing. Furthermore, the risk-benefit ratio must be carefully weighed in older adults with underlying cardiovascular disease, as they may be less able to tolerate the physiological stress of a systemic allergic reaction or the administration of epinephrine.
Symphoricarpos Albus Fruit extract is never for self-administration. It must be administered in a clinical setting by a healthcare professional.
If a dose of immunotherapy is missed, the next dose may need to be reduced depending on how much time has elapsed. If the interval exceeds the recommended schedule by more than a week, the healthcare provider will typically drop back to a previous lower dose level to ensure safety and avoid a systemic reaction.
An 'overdose' in the context of allergenic extracts refers to the administration of a dose that exceeds the patient's current tolerance level. This can lead to severe systemic reactions or anaphylaxis.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or skip appointments without medical guidance.
Most patients receiving Symphoricarpos Albus Fruit extract will experience some form of localized reaction. These are generally not dangerous but indicate the immune system is responding to the allergen.
> Warning: Stop taking Symphoricarpos Albus Fruit and call your doctor immediately if you experience any of these symptoms of anaphylaxis.
There are no known long-term 'toxic' side effects of Symphoricarpos Albus Fruit extract when used as directed. The primary risk of long-term use is the cumulative risk of having a systemic reaction over the course of several years of therapy. Some patients may develop 'serum sickness' (a delayed immune complex reaction), though this is extremely rare with modern purified extracts.
While Symphoricarpos Albus Fruit may not have a specific product-specific black box warning in all jurisdictions, the class of Allergenic Extracts carries a general warning regarding the risk of severe anaphylaxis.
Summary of Warning: Allergenic extracts can cause severe, life-threatening systemic reactions, including anaphylaxis and death. Patients with unstable asthma are at higher risk for fatal reactions. Extracts should only be administered in facilities equipped with personnel and medication (including epinephrine) to treat anaphylaxis. Patients must be observed for at least 30 minutes post-injection.
Report any unusual symptoms to your healthcare provider.
Symphoricarpos Albus Fruit extract is a potent biological substance. Its use is restricted to diagnostic and therapeutic protocols managed by specialists. Patients must be aware that even if they have tolerated previous injections, a systemic reaction can occur at any time during the course of therapy.
No FDA black box warnings specifically for 'Symphoricarpos Albus Fruit' are currently listed, but it falls under the general safety mandates for all non-standardized allergenic extracts. The primary warning emphasizes that anaphylaxis is a constant risk and that the product is contraindicated in patients with severe, unstable, or steroid-dependent asthma.
Symphoricarpos Albus Fruit extract generally does not interfere with the ability to drive. However, if a patient experiences a systemic reaction, dizziness, or is given antihistamines/epinephrine, they should not drive or operate heavy machinery until fully recovered.
There is no direct chemical interaction between alcohol and the extract. However, alcohol consumption can cause vasodilation, which may theoretically increase the rate of allergen absorption or mask early symptoms of an allergic reaction. It is generally advised to avoid alcohol for several hours before and after an injection.
Immunotherapy is typically a long-term commitment (3 to 5 years). Stopping the treatment prematurely will likely result in the return of allergic symptoms. There is no 'withdrawal syndrome' associated with stopping allergenic extracts, but the protective immunological benefits will gradually fade.
> Important: Discuss all your medical conditions with your healthcare provider before starting Symphoricarpos Albus Fruit.
There are no specific food interactions with Symphoricarpos Albus Fruit extract. However, patients with 'Oral Allergy Syndrome' may find that certain fruits (cross-reactive with the honeysuckle family) cause itching in the mouth; receiving an injection while experiencing these food-related symptoms could complicate the clinical picture.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.
Symphoricarpos Albus Fruit must NEVER be used in the following circumstances:
These conditions require a careful risk-benefit analysis by the physician:
Patients allergic to Symphoricarpos Albus Fruit may show cross-sensitivity to other members of the Caprifoliaceae family, including various species of Honeysuckle (Lonicera) and Elderberry (Sambucus). Caution should be exercised when testing these related allergens simultaneously.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Symphoricarpos Albus Fruit.
Pregnancy Category C: There are no adequate and well-controlled studies of Symphoricarpos Albus Fruit extract in pregnant women. The primary concern is not teratogenicity (birth defects) from the extract itself, but the danger of maternal anaphylaxis. Anaphylaxis can lead to maternal hypotension, uterine contractions, and fetal hypoxia. It is generally recommended that immunotherapy NOT be initiated during pregnancy. If a woman becomes pregnant while on a stable maintenance dose, the physician may choose to continue the therapy but will usually not increase the dose until after delivery.
It is not known whether the components of Symphoricarpos Albus Fruit extract are excreted in human milk. Because the extract consists of proteins that are likely digested in the infant's gastrointestinal tract, the risk to a nursing infant is considered very low. Breastfeeding is generally not a contraindication for receiving allergy shots.
Allergen immunotherapy is generally considered safe for children age 5 and older. The efficacy in younger children is less well-documented, and the risks of systemic reactions are harder to manage. Pediatric patients must be monitored closely for 'behavioral' signs of an allergic reaction, such as sudden irritability or lethargy, as they may not be able to describe 'throat tightness.'
Clinical studies of allergenic extracts often do not include sufficient numbers of subjects aged 65 and over. In elderly patients, the physician must consider the higher prevalence of comorbid conditions like coronary artery disease and COPD. The use of epinephrine in the elderly carries a higher risk of triggering arrhythmias or myocardial ischemia.
No dosage adjustments are required. The proteins in the extract are not systemically absorbed in quantities that would affect or be affected by renal function.
No dosage adjustments are required. Hepatic metabolism does not play a role in the clearance of allergenic extracts administered subcutaneously or via skin testing.
> Important: Special populations require individualized medical assessment.
Symphoricarpos Albus Fruit extract functions as an immunomodulator. In sensitized individuals, the 'major allergens' (specific proteins) in the fruit bind to IgE antibodies on mast cells and basophils. This triggers a Type I hypersensitivity reaction. During therapeutic desensitization, the repeated administration of these proteins leads to:
The pharmacodynamic effect of a diagnostic dose is visible within 15-20 minutes (the 'immediate phase'). The therapeutic effect of immunotherapy develops slowly over months. Full clinical benefit (symptom reduction) typically requires 6 to 12 months of consistent treatment.
| Parameter | Value |
|---|---|
| Bioavailability | N/A (Subcutaneous/Local) |
| Protein Binding | Primarily to IgE/IgG antibodies |
| Half-life | Proteins degraded within hours/days |
| Tmax | 15-30 minutes (for local reaction) |
| Metabolism | Proteolysis by macrophages |
| Excretion | Cellular degradation products |
Symphoricarpos Albus Fruit extract is an aqueous-phenolic or glycerinated extract containing a mixture of water-soluble proteins, glycoproteins, and polysaccharides. The molecular weights of the relevant allergens typically range from 10 to 70 kDa. It is a clear to slightly amber liquid. The extract is non-standardized, meaning its potency is defined by the weight of the raw material used per volume of extracting fluid (e.g., 1:20 w/v).
Symphoricarpos Albus Fruit belongs to the Non-Standardized Plant Allergenic Extract [EPC] class. It is categorized alongside other berry and fruit extracts used in allergy medicine. It is distinct from 'Standardized' extracts like those for Grass Pollen or Dust Mites, which have federally mandated potency units.
Medications containing this ingredient
Common questions about Symphoricarpos Albus Fruit
Symphoricarpos Albus Fruit extract is primarily used for the diagnosis and treatment of allergies to the common snowberry plant. Healthcare providers use it in skin prick tests to confirm if a patient is sensitized to the plant's proteins. If a significant allergy is found, the extract can also be used in immunotherapy, commonly known as allergy shots. This process involves giving small, increasing doses of the extract to help the immune system build a tolerance. It is not used to treat acute symptoms but rather to provide long-term relief from allergic reactions.
The most common side effects are localized reactions at the site of the skin test or injection. These include redness, itching, and a raised bump known as a wheal, which typically appear within minutes. Some patients may also experience 'late-phase' reactions, where the injection site becomes swollen and sore several hours later. These local symptoms are generally mild and resolve on their own within a day or two. However, any swelling larger than the palm of your hand should be reported to your doctor.
It is generally recommended to avoid alcohol on the day you receive an injection of Symphoricarpos Albus Fruit extract. Alcohol can cause your blood vessels to dilate, which might increase the speed at which the allergen is absorbed into your system, potentially increasing the risk of a reaction. Furthermore, alcohol can mask the early warning signs of a systemic allergic reaction, such as flushing or dizziness. To ensure maximum safety, wait at least 24 hours after your injection before consuming alcohol. Always consult your allergist for their specific office policy regarding alcohol and immunotherapy.
Symphoricarpos Albus Fruit extract is generally not started during pregnancy because of the risk of anaphylaxis, which can be dangerous for both the mother and the developing baby. However, if a patient is already on a stable maintenance dose and becomes pregnant, many doctors allow the treatment to continue. The dosage is typically not increased during the pregnancy to minimize the risk of a new reaction. If you are planning to become pregnant or find out you are pregnant, notify your allergist immediately. They will perform a risk-benefit analysis to determine the safest course of action for your specific situation.
When used for diagnostic skin testing, the extract works almost immediately, with results visible within 15 to 20 minutes. For therapeutic immunotherapy, however, the process is much slower. Most patients begin to notice a reduction in their allergy symptoms after 6 to 12 months of regular injections. The full benefit of the treatment is usually reached after 2 to 3 years of consistent therapy. It is important to remain patient and follow the injection schedule strictly to achieve the best long-term results.
Yes, you can stop taking the injections at any time without experiencing physical withdrawal symptoms, as the extract is not addictive. However, stopping the treatment before the recommended 3-to-5-year course is finished usually means your allergy symptoms will eventually return. The immune tolerance built up during the treatment requires a full course to become 'permanent.' If you need to stop treatment due to side effects or life changes, discuss a tapering or pause plan with your healthcare provider. Do not expect the allergic protection to last if the treatment is discontinued prematurely.
If you miss a scheduled immunotherapy injection, contact your allergist's office as soon as possible to reschedule. Do not attempt to 'double up' on your next dose. Depending on how much time has passed since your last injection, your doctor may need to reduce the dose for your next visit to ensure safety. Missing multiple doses may require you to move back several steps in your build-up schedule. Consistency is the key to both the safety and the effectiveness of allergen immunotherapy.
There is no clinical evidence to suggest that Symphoricarpos Albus Fruit extract causes weight gain. The extract consists of proteins and stabilizers administered in very small quantities that do not affect the body's metabolism or appetite. If you experience weight changes while on immunotherapy, it is likely due to other factors or medications, such as oral corticosteroids sometimes used to manage severe allergy symptoms. Always discuss any unexpected physical changes with your healthcare provider. Maintaining a healthy lifestyle is encouraged throughout the duration of your allergy treatment.
While many medications are safe to take with this extract, some can pose serious risks. Beta-blockers used for blood pressure or heart conditions are the most concerning, as they can prevent life-saving treatment from working if you have a severe reaction. Antihistamines will not cause a dangerous interaction but will hide your skin's reaction, making diagnostic tests inaccurate. You must provide your allergist with a complete list of all prescriptions, over-the-counter drugs, and herbal supplements you are taking. They will determine if any of your current medications need to be adjusted before you start treatment.
The concept of 'generic' vs. 'brand name' is slightly different for allergenic extracts compared to traditional pills. Symphoricarpos Albus Fruit extract is produced by several specialized biological laboratories, and while the 'brand' may change, the active ingredient remains the same snowberry fruit extract. These are often referred to by their manufacturer's name. Because these are complex biological products, they are not considered interchangeable in the same way generic ibuprofen is. Your doctor will typically stick with one manufacturer's extract for the duration of your treatment to ensure consistency in your dosing.